Evidence map›Paper›PMID 40767156›Full record

ArticleACS nano2025

Electrospun CoFe

Zexuan Wang, María F Navarro Poupard, Ramsundar Rani Mohan, Loukya Boddapati, Jijun Zhang, Saeed Kamali, Chiara Biz, Mauro Fianchini, Francis Leonard Deepak, Jose Gracia and 2 more

Abstract read
In one paragraph

Article in ACS nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zexuan WangInternational Iberian Nanotechnology Laboratory, Braga 4715-330, Portugal.
María F Navarro PoupardInternational Iberian Nanotechnology Laboratory, Braga 4715-330, Portugal.
Ramsundar Rani MohanInternational Iberian Nanotechnology Laboratory, Braga 4715-330, Portugal.
Loukya BoddapatiInternational Iberian Nanotechnology Laboratory, Braga 4715-330, Portugal.ORCID 0000-0002-4107-4546
Jijun ZhangInternational Iberian Nanotechnology Laboratory, Braga 4715-330, Portugal.
Saeed KamaliDepartment of Physics and Astronomy, Middle Tennessee State University, Murfreesboro, Tennessee 37132, United States.
Chiara BizMagnetoCat SL, Calle General Polavieja 9, 3Izq, Alicante 03012, Spain.ORCID 0000-0003-3104-552X
Mauro FianchiniMagnetoCat SL, Calle General Polavieja 9, 3Izq, Alicante 03012, Spain.ORCID 0000-0003-2619-7932
Francis Leonard DeepakInternational Iberian Nanotechnology Laboratory, Braga 4715-330, Portugal.ORCID 0000-0002-3833-1775
Jose GraciaMagnetoCat SL, Calle General Polavieja 9, 3Izq, Alicante 03012, Spain.
Laura M SalonenInternational Iberian Nanotechnology Laboratory, Braga 4715-330, Portugal.ORCID 0000-0001-8194-6014
Yury V Kolen'koInternational Iberian Nanotechnology Laboratory, Braga 4715-330, Portugal.ORCID 0000-0001-7493-1762

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In view of a future green hydrogen economy, the development of efficient, platinum-group-metal-free catalysts for the oxygen evolution reaction (OER) remains an important goal. Magnetic enhancement of oxygen-evolving catalysis is an interesting strategy to boost catalyst activity, as it can promote the formation of triplet oxygen through spin polarization. Magnetoelectrochemistry can rely on the use of an external magnetic field or the internal magnetic order of the catalyst. Therefore, synthesis strategies that allow for tailoring the magnetic properties of magnetic catalyst materials are of high interest. Here, we report on the synthesis of CoFe

Indexed as

magnetic catalystsmagnetic nanofibersmicrostructurenanotechnologyoxygen evolution reactionspin polarization

Identifiers

PMID40767156
PMCPMC12368993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.